Details

Autor(en) / Beteiligte

• Hersh, Elliot V
• Moore, Paul A
• Papas, Athena S
• Goodson, J Max
• Navalta, Laura A
• Rogy, Siegfried
• Rutherford, Bruce
• Yagiela, John A

Titel

Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adults

Ist Teil von

• The Journal of the American Dental Association (1939), 2008-08, Vol.139 (8), p.1080-1093

Ort / Verlag

England

Erscheinungsjahr

2008

Quelle

MEDLINE

Beschreibungen/Notizen

• The authors conducted two multicenter, randomized, double-blinded, controlled Phase III clinical trials to study the efficacy and safety of phentolamine mesylate (PM) in shortening the duration and burden of soft-tissue anesthesia. The study involved 484 subjects who received one of four commercially available local anesthetic solutions containing vasoconstrictors for restorative or scaling procedures. On completion of the dental procedure, subjects randomly received a PM or a sham injection (an injection in which a needle does not penetrate the soft tissue) in the same site as the local anesthetic injection. The investigators measured the duration of soft-tissue anesthesia by using standardized lip- and tongue-tapping procedures every five minutes for five hours. They also evaluated functional measures and subject-perceived altered function, sensation, appearance and safety. Median recovery times in the lower lip and tongue for subjects in the PM group were 70 minutes and 60 minutes, respectively. Median recovery times in the lower lip and tongue for subjects in the sham group were 155 minutes and 125 minutes, respectively. Upper lip median recovery times were 50 minutes for subjects in the PM group and 133 minutes for subjects in the sham group. These differences were significant (P < .0001). Recovery from actual functional deficits and subject-perceived altered function, sensation and appearance also showed significant differences between the PM and the sham groups. PM was efficacious and safe in reducing the duration of local anesthetic- induced soft-tissue numbness and its associated functional deficits. Clinicians can use PM to accelerate reversal of soft-tissue anesthesia and the associated functional deficits.